Orchid Chemicals & Pharmaceuticals (Orchid), the Chennai-based pharma major, has received approval from the USFDA for its ANDA (Abbreviated New Drug Application) for Venlafaxine Extended Release (ER) Capsules in the 37.5 mg, 75 mg and 150 mg strengths.
Recently, the company was in active dialogue with the Tamil Nadu Pollution Control Board (TNPCB) officials and was confident of resolving the issues and bringing the plant to a fully operational stage at the earliest. Earlier, the company’s Cephalosporin API manufacturing facility located in Alathur at Chennai was issued a closure notice by the TNPCB citing some non-compliance with regard to the disposal of solid waste.
Orchid Chemicals & Pharmaceuticals (Orchid) is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: